Hospital material management has been identified as one key cost containment lever to
cope with steadily increasing healthcare costs in industrialized countries. The purpose of …

Drug shortages continue at crisis levels in the United States, with no end in sight. Extensive
research in disparate areas has been conducted to explore the impact that shortages have …

Background Improving antibiotic use has the potential to decrease healthcare costs by
reducing the incidence of antibiotic-resistant infections, antibiotic-associated adverse …

The use of biologics is widespread and has become an essential element in cancer
treatment and supportive care management; based on current patterns of drug development …

A new antimicrobial stewardship program can be overwhelmed at the breadth of
interventions and education required to conduct a successful program. The expression “low …

As supply chain costs constitute a large portion of hospitals' operating expenses and with
$27.7 billion spent by the US hospitals on drugs alone in 2009, improving medication …

Background Only a small amount of research has focused on the relationship between socio-
economic status (SES) and geographic access to prescription medications at community …

Biologics play a key role in cancer treatment and are principal components of many
therapeutic regimens. However, they require complex manufacturing processes, resulting in …

Biological medicines contain a biological substance that is produced by or derived from a
living organism. The active substances of biologicals are usually larger and more complex …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …